Abbott ID Now

Abbott ID NOW COVID-19 is an automated rapid PCR Point of care test which has been authorised by FDA USA under an emergency use authorization for use by authorized laboratories and patient care settings. It uses a technology of isothermal nucleic acid amplification for the qualitative detection of SARS-CoV-2 viral RNA and the target is RdRp segment of SARS-CoV-2 viral RNA. The result can be given as early as 13 minutes or less once the sample is loaded in the instrument. The sample used for this assay is a dry swab collected from nasal cavity, nasopharynx (sample collected by swab from deep inside the nose till the nasopharynx is reached) or throat (swab taken from the tonsil region and around inside the mouth). VTM (Viral transport media) which is usually collected for RTPCR test otherwise cannot be used in this assay.

A Positive COVID-19 result by Abbott ID NOW COVID-19 do not rule out bacterial infection or coinfection with other viruses. A quantification cannot be done by this method. COVID-19 Negative is taken as presumptive and, if doesn’t correlate with the symptoms of the patient then other molecular test is advised to rule out. Sometime the test might be invalid where the test is repeated if same a fresh sample is asked.

Abbott ID NOW COVID-19 Test is a convenient, reliable and a good Point of care test for SARS-CoV-2 which can give faster result for clinical management.